The role of data mining in pharmacovigilance

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Expert Opinion on Drug Safety

• Publication date

  2005-09-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1517/14740338.4.5.929PMID 16111454
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Case reports of dobutamine-induced myoclonia in severe renal failure: potential of emerging pharmacovigilance technologies.

  2005cited by this paper
• Comparing data mining methods on the VAERS database

  2005cited by this paper
• Communication of findings in pharmacovigilance: use of the term “signal” and the need for precision in its use

  2005cited by this paper
• A hit-miss model for duplicate detection in the WHO drug safety database

  2005cited by this paper
• Data Mining in Pharmacovigilance

  2005cited by this paper
• Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.

  2005cited by this paper
• Evaluation of Suspected Adverse Drug Reactions—Reply

  2005cited by this paper
• Potential Utility of Data‐Mining Algorithms for Early Detection of Potentially Fatal/Disabling Adverse Drug Reactions: A Retrospective Evaluation

  2005cited by this paper
• Evaluation of suspected adverse drug reactions.

  2005cited by this paper
• Valproate‐induced parkinsonism: Use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an “old” drug

  2005cited by this paper
• Endotoxin-Like Reactions With Intravenous Gentamicin Results From Pharmacovigilance Tools Under Investigation

  2005cited by this paper
• Data mining in pharmacovigilance: the need for a balanced perspective.

  2005cited by this paper
• Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis

  2005cited by this paper
• Practical Considerations in Developing an Automated Signaling Program within a Pharmacovigilance Department

  2004cited by this paper
• Safety Related Drug-Labelling Changes

  2004cited by this paper
• Expecting the unexpected--drug safety, pharmacovigilance, and the prepared mind.

  2004cited by this paper
• Data Mining of the Australian Adverse Drug Reactions Database

  2004cited by this paper
• Drug-induced pancreatitis: lessons in data mining.

  2004cited by this paper
• Gene mining: a novel and powerful ensemble decision approach to hunting for disease genes using microarray expression profiling

  2004cited by this paper
• Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database

  2004cited by this paper
• Trimethoprim-induced hyperkalaemia -- lessons in data mining.

  2004influential reference
• Using MedDRA

  2004cited by this paper
• A case report of rhabdomyolysis with pentamidine that prompted a retrospective evaluation of a pharmacovigilance tool under investigation.

  2004cited by this paper
• Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms

  2004cited by this paper
• Data mining, drug safety, and molecular pharmacology: potential for collaboration

  2004cited by this paper
• Comparison of data mining methodologies using Japanese spontaneous reports

  2004cited by this paper
• Letter to the Editor—Re: Almenoff et al., ‘Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting’, (PDS, 2003; 12(6); 517–521)

  2004cited by this paper
• Application of an Empiric Bayesian Data Mining Algorithm to Reports of Pancreatitis Associated with Atypical Antipsychotics

  2004cited by this paper
• Pharmacovigilance in the 21st Century: New Systematic Tools for an Old Problem

  2004cited by this paper
• Gene mining: a novel and powerful ensemble decision approach to hunting for disease genes using microarray expression profiling.

  2004cited by this paper
• Early Postmarketing Drug Safety Surveillance: Data Mining Points to Consider

  2004influential reference
• Practical pharmacovigilance analysis strategies.

  2003cited by this paper
• Spontaneous Reporting System Modelling for Data Mining Methods Evaluation in Pharmacovigilance

  2003cited by this paper
• Empirical Bayesian data mining for discovering patterns in post-marketing drug safety

  2003cited by this paper
• Methods and Pitfalls in Searching Drug Safety Databases Utilising the Medical Dictionary for Regulatory Activities (MedDRA)1

  2003cited by this paper
• Data mining issues and opportunities for building nursing knowledge

  2003cited by this paper
• Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post‐marketing setting

  2003cited by this paper
• Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions

  2003cited by this paper
• The effect of backgrounds in safety analysis: the impact of comparison cases on what you see

  2003cited by this paper
• A Brief Primer on Automated Signal Detection

  2003cited by this paper
• Statistical Techniques for Signal Generation

  2002cited by this paper
• Different Risks for NSAID-Induced Anaphylaxis

  2002cited by this paper
• Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs

  2002cited by this paper
• Non-sedating antihistamine drugs and cardiac arrhythmias -- biased risk estimates from spontaneous reporting systems?

  2002cited by this paper
• Image mining: issues, framework, a generic tool and its application to medical-image diagnosis

  2002cited by this paper
• Use of Measures of Disproportionality in Pharmacovigilance

  2002cited by this paper
• A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions

  2002cited by this paper
• Effects of Coding Dictionary on Signal Generation

  2002cited by this paper
• Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA’s Spontaneous Reports Database

  2002cited by this paper
• Are Case-Based Reasoning and Dissimilarity-Based Classification Two Sides of the Same Coin?

  2001cited by this paper
• Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

  2001influential reference
• Association between terbinafine and arthralgia, fever and urticaria: symptoms or syndrome?

  2001cited by this paper
• Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study

  2001cited by this paper
• Recurrent Asymptomatic Bradycardia Episodes after Cisplatin Infusion

  2001cited by this paper
• Some US Food and Drug Administration Perspectives on Data Mining for Pediatric Safety Assessment

  2001cited by this paper
• Detecting drug–drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs

  2000cited by this paper
• A Retrospective Evaluation of a Data Mining Approach to Aid Finding New Adverse Drug Reaction Signals in the WHO International Database

  2000cited by this paper
• Data Mining for Fun and Profit

  2000cited by this paper
• Attitudinal survey of voluntary reporting of adverse drug reactions.

  1999cited by this paper
• Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System

  1999cited by this paper
• Applied Regression Analysis@@@Applied Regression Analysis: A Research Tool

  1999cited by this paper
• Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole.

  1999cited by this paper
• Underreporting of Adverse Drug Reactions: Attitudes of Irish doctors

  1999cited by this paper
• A Bayesian neural network method for adverse drug reaction signal generation

  1998cited by this paper
• Principles of Signal Detection in Pharmacovigilance

  1997cited by this paper
• Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district.

  1997cited by this paper
• Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union

  1997cited by this paper
• Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom.

  1995cited by this paper
• False-positives in spontaneous reporting: should we worry about them?

  1994cited by this paper
• Nature's Capacities and Their Measurement

  1993cited by this paper
• Attitudes to adverse drug reaction reporting in the Northern Region.

  1992cited by this paper
• Nature’s Capacities and their Measurement

  1991cited by this paper
• On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Section 9

  1990cited by this paper
• [On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Section 9.] Comment: Neyman (1923) and Causal Inference in Experiments and Observational Studies

  1990cited by this paper
• The central role of the propensity score in observational studies for causal effects

  1983cited by this paper
• The detection of adverse reactions to therapeutic drugs.

  1982cited by this paper
• Smoking and lung cancer: recent evidence and a discussion of some questions.

  1959cited by this paper
• WHO Technical Report

  1954cited by this paper

• Hepatobiliary disorders associated with TNF-α inhibitors: a pharmacovigilance analysis of FAERS and JADER

  2026cites this paper
• Topically administered macrocyclic lactone products, including eprinomectin, demonstrate comparable neurological safety in cats based on pharmacovigilance data.

  2026cites this paper
• Charting and Sidestepping the Pitfalls of Disproportionality Analysis

  2025cites this paper
• Paradoxical psoriasis in pediatric tumor necrosis factor-α inhibitor therapy database.

  2025cites this paper
• Pharmacovigilance Analysis of Lifitegrast-Associated Adverse Events Using the FDA Adverse Event Reporting System (FAERS) Database

  2025cites this paper
• Recommendations to Enable Broader Use of Real‐World Evidence to Inform Decision‐Making Throughout Pharmacovigilance Signal Management

  2025cites this paper
• Prescribed Drugs and Interpersonal Violence: A Case–Non-Case Study in the Spanish Pharmacovigilance Database

  2025cites this paper
• Safety assessment of tolvaptan: real-world adverse event analysis using the FAERS database

  2025cites this paper
• Comparative safety evaluation of pentavalent (DTaP-IPV-Hib) and hexavalent (DTaP-IPV-Hib-HepB) vaccines in infants: a real-world analysis based on VAERS

  2025cites this paper
• Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination

  2025cites this paper
• Suspected statin-related adverse drug reactions: analysis of spontaneous reports in Hubei Province, China (2014-2022).

  2025cites this paper
• Adverse drug events associated with sodium zirconium cyclosilicate: A real-world pharmacovigilance study based on the FAERS database

  2025cites this paper
• A pharmacovigilance study of the association between linaclotide/plecanatide and muscle spasms based on food and drug administration adverse event reporting system

  2025cites this paper
• How AI and Machine Learning Stand for Used in Keeping an Eye on Drug Safety a Review Article

  2025cites this paper
• New Adverse Drug Reaction Signals from 2017 to 2021—Genuine Alerts or False Alarms?

  2024influential citation
• Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database

  2024cites this paper
• Delayed immune-related adverse events profile associated with immune checkpoint inhibitors: a real-world analysis

  2024cites this paper
• A Review of Traditional and Modern Approaches in Pharmacovigilance for Hypertension and Kidney Disease Treatments

  2024cites this paper
• The BPgWSP test: a Bayesian Weibull Shape Parameter signal detection test for adverse drug reactions

  2024cites this paper
• Data mining applications in risk research: A systematic literature review

  2024cites this paper
• Vancomycin and linezolid: severe cutaneous adverse reactions to drugs.

  2024cites this paper
• A Retrospective Observational Study of Adverse Drug Reactions (ADR) Reported to ADR Monitoring Centre from 2010 to 2020.

  2024cites this paper
• Anaphylactic risk associated with iodinated and gadolinium-based contrast media

  2024cites this paper
• Streamlining Considerations for Safety Measures: A Predictive Model for Addition of Clinically Significant Adverse Reactions to Japanese Drug Package Inserts.

  2024cites this paper
• Drug-associated porphyria: a pharmacovigilance study

  2024cites this paper
• Sequential FDR and pFDR Control Under Arbitrary Dependence, with Application to Pharmacovigilance Database Monitoring

  2024cites this paper
• Predicting the Addition of Information Regarding Clinically Significant Adverse Drug Reactions to Japanese Drug Package Inserts Using a Machine-Learning Model

  2023cites this paper
• Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database

  2023cites this paper
• A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)

  2023cites this paper
• PARP inhibitor-related haemorrhages: What does the real-world study say?

  2023cites this paper
• A pharmacovigilance study of association between proton‐pump inhibitors and rhabdomyolysis event based on FAERS database

  2023cites this paper
• Analysis of COVID-19 vaccine-related adverse event reports following COVID-19 vaccine BNT162b2 mRNA-1273 and Ad.26.COV2.S based on the US vaccine adverse event reporting system

  2023cites this paper
• When I use a word . . . Medical definitions: Goldfinger events

  2023cites this paper
• Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System

  2023cites this paper
• Pharmacovigilance studies without a priori hypothesis systematic review highlights inappropriate multiple testing correction procedures.

  2023cites this paper
• Kernelized Multitask Learning Method for Personalized Signaling Adverse Drug Reactions

  2023cites this paper
• Severe cutaneous adverse reactions associated with immune checkpoint inhibitors therapy and anti-VEGF combination therapy: a real-world study of the FDA adverse event reporting system

  2023cites this paper
• Application of machine learning models to animal health pharmacovigilance: A proof-of-concept study.

  2023cites this paper
• Post-marketing safety of anti-IL-5 monoclonal antibodies (mAbs): an analysis of the FDA Adverse Event Reporting System (FAERS)

  2023cites this paper
• Prescribed Drugs and Self-Directed Violence: A Descriptive Study in the Spanish Pharmacovigilance Database

  2023cites this paper
• Janus kinase inhibitor—Tofacitinib associated with pemphigus: an analysis of the FDA adverse event reporting system data

  2023cites this paper
• Potential Signals of COVID-19 as an Effect Modifier of Adverse Drug Reactions.

  2023cites this paper
• OAE-based data mining and modeling analysis of adverse events associated with three licensed HPV vaccines

  2022cites this paper
• Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database

  2022cites this paper
• On the use of the likelihood ratio test methodology in pharmacovigilance

  2022influential citation
• Risk monitoring and pharmacovigilance of programmed cell death protein 1 / programmed cell death 1 ligand 1 in cancer patients after solid organ transplantation.

  2022cites this paper
• Neuromuscular junction dysfunctions due to immune checkpoint inhibitors therapy: An analysis of FAERS data in the past 15 years

  2022cites this paper
• Does eltrombopag lead to thrombotic events? A pharmacovigilance study of the FDA adverse event reporting system

  2022cites this paper
• Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database

  2022cites this paper
• A smart hospital-driven approach to precision pharmacovigilance.

  2022cites this paper
• Stevens-Johnson Syndrome Following Non-steroidal Anti-inflammatory Drugs: A Real-World Analysis of Post-marketing Surveillance Data

  2022cites this paper
• "Various approaches to postmarketing drug safety monitoring"

  2022cites this paper
• Fetal Congenital Cardiac and Vascular Disorders Associated with Sertraline Treatment during Pregnancy: Analysis of FAERS Data

  2022cites this paper
• Syndrome of inappropriate antidiuretic hormone secretion is associated with different proton pump inhibitor use: a pharmacovigilance study

  2022cites this paper
• Generalised weibull model-based approaches to detect non-constant hazard to signal adverse drug reactions in longitudinal data

  2022cites this paper
• Stevens-Johnson Syndrome Following Vancomycin and Linezolid: A Real-World Analysis of Post-Marketing Surveillance Data

  2022cites this paper
• Immune Checkpoint Inhibitor–Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study

  2021cites this paper
• RETRACTED ARTICLE: Analysis and Prediction of Adverse Reaction of Drugs with Machine Learning Models for Tracking the Severity

  2021cites this paper
• Pharmacovigilance Bibliometrics: Visualizing Thematic Development in the Category of Pharmacology and Pharmacy in Web of Science

  2021cites this paper
• Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab

  2021cites this paper
• Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury via mitochondrial or other mechanisms

  2021cites this paper
• Cardiotoxicity in Biological Agent-Targeted Therapy for Rheumatoid Arthritis: ADR Signal Mining and Analysis of Food and Drug Administration Adverse Event Reporting System Database

  2021cites this paper
• Assessing taxane-associated adverse events using the FDA adverse event reporting system database

  2021cites this paper
• Clinical profile of acute pancreatitis following treatment with protease inhibitors: a real-world analysis of post-marketing surveillance data

  2021cites this paper
• Post-Market Surveillance of Consumer Products: Framework for Adverse Event Management.

  2021cites this paper
• Risk comparison of beta‐lactam‐induced anaphylaxis: Therapeutic stratification analysis in a Vietnamese pharmacovigilance database

  2021cites this paper
• Safety of traditional Chinese medicine injection based on spontaneous reporting system from 2014 to 2019 in Hubei Province, China

  2021cites this paper
• Kidney Injury Following Ibuprofen and Acetaminophen: A Real-World Analysis of Post-Marketing Surveillance Data

  2021cites this paper
• Anaphylaxis Associated With Allergen Specific Immunotherapy, Omalizumab, and Dupilumab: A Real World Study Based on the US Food and Drug Administration Adverse Event Reporting System

  2021cites this paper
• Neuropsychiatric side reactions of leukotriene receptor antagonist, antihistamine, and inhaled corticosteroid: A real-world analysis of the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS)

  2021cites this paper
• Status and Safety Signals of Cephalosporins in Children: A Spontaneous Reporting Database Study

  2021cites this paper
• Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions

  2020cites this paper
• Aromatase inhibitors associated osteonecrosis of jaw: signal refining to identify pseudo safety signals

  2020cites this paper
• A compound attributes-based predictive model for drug induced liver injury in humans

  2020influential citation
• Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system.

  2020cites this paper
• An evaluation of statistical approaches to postmarketing surveillance

  2020influential citation
• Acute pancreatitis following treatment with protease inhibitors, which may be potential therapeutics for COVID-19: A real-world analysis of postmarketing surveillance data

  2020cites this paper
• Bayesian hierarchical methods in the detection of potentially teratogenic first‐trimester medications

  2020cites this paper
• A stratification method based on clustering for the minimization of data masking effect in signal detection

  2020cites this paper
• Utilizing graphics processing unit to accelerate drug-symptom association mining

  2020cites this paper
• The role of advanced technologies supplemented with traditional methods in pharmacovigilance sciences.

  2020cites this paper
• Fournier Gangrene Associated with Sodium-Glucose Cotransporter-2 Inhibitors: A Pharmacovigilance Study with Data from the U.S. FDA Adverse Event Reporting System

  2020cites this paper
• Hemorrhage Risk Profiles among Different Antithrombotic Regimens: Evidence from a Real-World Analysis of Postmarketing Surveillance Data

  2020cites this paper
• Evaluation of signal detection algorithms within the Elanco Animal Health Pharmacovigilance database.

  2020cites this paper
• Safety of BRAF+MEK Inhibitor Combinations: Severe Adverse Event Evaluation

  2020cites this paper
• Variable association of atypical femur fracture and osteonecrosis of jaw with bisphosphonates and denosumab use: Drug-safety surveillance study

  2020cites this paper
• Aneurysm and Artery Dissection Following the Use of Vascular Endothelial Growth Factor Inhibitor: A Real‐World Analysis Using a Spontaneous Reporting System

  2020cites this paper
• Do sodium–glucose cotransporter 2 inhibitors lead to fracture risk? A pharmacovigilance real‐world study

  2020cites this paper
• Pharmacoepidemiology in the Prevention of Adverse Drug Reactions

  2019cites this paper
• New Insights in Computational Methods for Pharmacovigilance: E-Synthesis, a Bayesian Framework for Causal Assessment

  2019cites this paper
• Mining Sequential Patterns of Diseases Contracted and Medications Prescribed before the Development of Stevens-Johnson Syndrome in Taiwan

  2019cites this paper
• Early signal detection of adverse events following influenza vaccination using proportional reporting ratio, Victoria, Australia

  2019cites this paper
• Signal Detection for Cardiovascular Adverse Events of DPP-4 Inhibitors Using the Korea Adverse Event Reporting System Database, 2008–2016

  2019cites this paper
• Pharmacovigilance as Scientific Discovery: An Argument for Trans-Disciplinarity

  2019cites this paper
• Development of a Controlled Vocabulary-Based Adverse Drug Reaction Signal Dictionary for Multicenter Electronic Health Record-Based Pharmacovigilance

  2019cites this paper
• Signal Management and Methods of Signal Detection

  2019cites this paper
• Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases

  2019cites this paper
• A Review of the Food and Drug Administration Adverse Event Reporting System for Tramadol-Related Hypoglycemia

  2019cites this paper
• Pharmacovigilance in perspective: drug withdrawals, data mining and policy implications

  2019cites this paper
• An Alternative to Disproportionality: A Frequency-Based Method for Pharmacovigilance Data Mining

  2018cites this paper